Cargando…

Downregulation of interferon-γ-induced protein 10 in the tears of patients with Stevens-Johnson syndrome with severe ocular complications in the chronic stage

OBJECTIVES: Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are acute inflammatory vesiculobullous reactions of the skin and mucosa such as the ocular surface, oral cavity and genitals. Severe ocular complications (SOC) arise in some patients with SJS/TEN diagnosed by dermatologi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ueta, Mayumi, Nishigaki, Hiromi, Sotozono, Chie, Kinoshita, Shigeru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5721640/ https://www.ncbi.nlm.nih.gov/pubmed/29354711 http://dx.doi.org/10.1136/bmjophth-2017-000073

Ejemplares similares

Predictive biomarkers for the progression of ocular complications in chronic Stevens-Johnson syndrome and toxic Eeidermal necrolysis
por: Yoshikawa, Yamato, et al.
Publicado: (2020)

Japan: Diagnosis and Management of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Sotozono, Chie, et al.
Publicado: (2021)

Categorization of the Ocular Microbiome in Japanese Stevens–Johnson Syndrome Patients With Severe Ocular Complications
por: Ueta, Mayumi, et al.
Publicado: (2021)

Plasma Lipid Profiling of Patients with Chronic Ocular Complications Caused by Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis
por: Saito, Kosuke, et al.
Publicado: (2016)

Gene expression analysis of conjunctival epithelium of patients with Stevens-Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2019)

HLA class I and II gene polymorphisms in Stevens-Johnson syndrome with ocular complications in Japanese
por: Ueta, Mayumi, et al.
Publicado: (2008)

HLA-A*0206 with TLR3 Polymorphisms Exerts More than Additive Effects in Stevens-Johnson Syndrome with Severe Ocular Surface Complications
por: Ueta, Mayumi, et al.
Publicado: (2012)

Long-Term Benefits of Tear Exchangeable Limbal-Rigid Contact Lens Wear Therapy in Stevens–Johnson Syndrome Cases
por: Yoshikawa, Yamato, et al.
Publicado: (2023)

Regulation of gene expression by miRNA-455-3p, upregulated in the conjunctival epithelium of patients with Stevens–Johnson syndrome in the chronic stage
por: Ueta, Mayumi, et al.
Publicado: (2020)

Challenges in the management of bilateral eyelid closure in Stevens-Johnson Syndrome
por: Aziza, Yulia, et al.
Publicado: (2022)

Strong association between hla-a*02:06 and acetaminophen-related stevens-johnson syndrome with severe mucosal involvements in the Japanese
por: Ueta, Mayumi, et al.
Publicado: (2014)

Association of HLA class I and II gene polymorphisms with acetaminophen-related Stevens–Johnson syndrome with severe ocular complications in Japanese individuals
por: Ueta, Mayumi, et al.
Publicado: (2019)

HLA-A*02:06 and PTGER3 polymorphism exert additive effects in cold medicine-related Stevens–Johnson syndrome with severe ocular complications
por: Ueta, Mayumi, et al.
Publicado: (2015)

Multi-state model for predicting ocular progression in acute Stevens-Johnson syndrome/toxic epidermal necrolysis
por: Kinoshita, Fumie, et al.
Publicado: (2021)

Pathogenesis of Stevens-Johnson Syndrome/Toxic Epidermal Necrolysis With Severe Ocular Complications
por: Ueta, Mayumi
Publicado: (2021)

HLA association with antipyretic analgesics-induced Stevens-Johnson Syndrome / toxic epidermal necrolysis with severe ocular surface complications in japanese patients
por: Nakamura, Ryosuke, et al.
Publicado: (2014)

Editorial: The Updated Understanding of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Kinoshita, Shigeru, et al.
Publicado: (2021)

Mapping of susceptible variants for cold medicine-related Stevens–Johnson syndrome by whole-genome resequencing
por: Kawai, Yosuke, et al.
Publicado: (2021)

In Silico Risk Assessment of HLA-A*02:06-Associated Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis Caused by Cold Medicine Ingredients
por: Isogai, Hideto, et al.
Publicado: (2013)

Association of Human Leukocyte Antigen Class 1 genes with Stevens Johnson Syndrome with severe ocular complications in an Indian population
por: Kannabiran, Chitra, et al.
Publicado: (2017)

Downregulation of IL-8, ECP, and total IgE in the tears of patients with atopic keratoconjunctivitis treated with rebamipide eyedrops
por: Ueta, Mayumi, et al.
Publicado: (2014)

Medication tendencies for inducing severe ocular surface symptoms in Japanese Stevens-Johnson Syndrome / toxic epidermal necrolysis patients
por: Saito, Yoshiro, et al.
Publicado: (2014)

Identification of HLA-A*02:06:01 as the primary disease susceptibility HLA allele in cold medicine-related Stevens-Johnson syndrome with severe ocular complications by high-resolution NGS-based HLA typing
por: Nakatani, Ken, et al.
Publicado: (2019)

Cold medicine-related Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications–phenotypes and genetic predispositions
por: Ueta, Mayumi
Publicado: (2016)

Difference in the plasma level of miR‐628‐3p in atopic dermatitis patients with/without atopic keratoconjunctivitis
por: Ueta, Mayumi, et al.
Publicado: (2021)

Human leukocyte antigen B*0702 is protective against ocular Stevens–Johnson syndrome/toxic epidermal necrolysis in the UK population
por: Butt, Gibran F., et al.
Publicado: (2021)

Trans-ethnic study confirmed independent associations of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe ocular surface complications
por: Ueta, Mayumi, et al.
Publicado: (2014)

Differences in gene regulation by TLR3 and IPS-1 signaling in murine corneal epithelial cells
por: Komai, Seitaro, et al.
Publicado: (2023)

Association of IKZF1 SNPs in cold medicine-related Stevens–Johnson syndrome in Thailand
por: Chantaren, Patchima, et al.
Publicado: (2019)

Independent strong association of HLA-A*02:06 and HLA-B*44:03 with cold medicine-related Stevens-Johnson syndrome with severe mucosal involvement
por: Ueta, Mayumi, et al.
Publicado: (2014)

The Ocular Microbiome in Stevens-Johnson Syndrome
por: Kittipibul, Thanachaporn, et al.
Publicado: (2021)

Prostaglandin E Receptor Subtype EP3 Expression in Human Conjunctival Epithelium and Its Changes in Various Ocular Surface Disorders
por: Ueta, Mayumi, et al.
Publicado: (2011)

Limbal-Rigid Contact Lens Wear for the Treatment of Ocular Surface Disorders: A Review
por: Aziza, Yulia, et al.
Publicado: (2022)

HLA genotypes and cold medicine-induced Stevens–Johnson syndrome/toxic epidermal necrolysis with severe ocular complications: a systematic review and meta-analysis
por: Tangamornsuksan, Wimonchat, et al.
Publicado: (2020)

Expression of prostaglandin E receptor subtype EP4 in conjunctival epithelium of patients with ocular surface disorders: case-control study
por: Ueta, Mayumi, et al.
Publicado: (2012)

Characteristics of meibomian gland dysfunction in patients with Stevens–Johnson syndrome
por: Shrestha, Tina, et al.
Publicado: (2019)

Prevalence of Chronic Ocular Complications in Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
por: Zyl, Lourens Van, et al.
Publicado: (2014)

Positive regulation of innate immune response by miRNA-let-7a-5p
por: Ueta, Mayumi, et al.
Publicado: (2023)

Anti-inflammatory effect of rebamipide on the ocular surface
por: Ueta, Mayumi, et al.
Publicado: (2013)

Stevens-Johnson Syndrome
por: Laun, Jake, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8ddormsn53mp0hs6usue8gtuc8